SyMap Medical Funding: $115M Raised, Series E (2021)
SyMap Medical is based in Suzhou, China. It has raised $115M in total funding. Latest round: Series E.
SyMap Medical funding overview
SyMap Medical is based in Suzhou, China. SyMap Medical has raised $115M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series E announced in December 2021. The round record for SyMap Medical runs through 2021; nothing later has been disclosed. Investors on record include Primavera Capital, VMS Group, Simiao Equity Investment, Sequoia Capital China. 4 distinct backers are named across the disclosed rounds.
SyMap Medical at a glance
Total raised
$115M
Latest round
Series E
Latest round date
December 2021
Headquarters
Suzhou, China
Notable investors
Primavera Capital, VMS Group, Simiao Equity Investment, Sequoia Capital China
Frequently asked about SyMap Medical funding
How much has SyMap Medical raised?
SyMap Medical has raised $115M in total disclosed funding across the rounds on record.
Who has invested in SyMap Medical?
Primavera Capital, VMS Group, Simiao Equity Investment, Sequoia Capital China are named among the investors backing SyMap Medical.
What was the latest SyMap Medical funding round?
The most recent disclosed round is a Series E, announced in December 2021.
Where is SyMap Medical based?
SyMap Medical is based in Suzhou, China.
When did SyMap Medical last raise?
The last disclosed SyMap Medical round closed in December 2021 at Series E.
SyMap Medical totals reflect disclosed capital only — undisclosed extensions and secondaries are excluded. Use the related companies in Suzhou below to benchmark round size and investor mix.
